Literature DB >> 25914175

Aryloxyethyl Thiocyanates Are Potent Growth Inhibitors of Trypanosoma cruzi and Toxoplasma gondii.

María N Chao1, Carolina Exeni Matiuzzi1, Melissa Storey2, Catherine Li2, Sergio H Szajnman1, Roberto Docampo2, Silvia N J Moreno2, Juan B Rodriguez3.   

Abstract

As a part of our project aimed at searching for new safe chemotherapeutic agents against parasitic diseases, several compounds structurally related to the antiparasitic agent WC-9 (4-phenoxyphenoxyethyl thiocyanate), which were modified at the terminal phenyl ring, were designed, synthesized, and evaluated as growth inhibitors against Trypanosoma cruzi, the etiological agent of Chagas disease, and Toxoplasma gondii, the parasite responsible of toxoplasmosis. Most of the synthetic analogues exhibited similar antiparasitic activity and were slightly more potent than our lead WC-9. For example, two trifluoromethylated derivatives exhibited ED50 values of 10.0 and 9.2 μM against intracellular T. cruzi, whereas they showed potent action against tachyzoites of T. gondii (ED50 values of 1.6 and 1.9 μM against T. gondii). In addition, analogues of WC-9 in which the terminal aryl group is in the meta position with respect to the alkyl chain bearing the thiocyanate group showed potent inhibitory action against both T. cruzi and T. gondii at the very low micromolar range, which suggests that a para-phenyl substitution pattern is not necessary for biological activity.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antiparasitic agents; biological activity; chemotherapeutic agents; inhibitors; structure-activity relationships

Mesh:

Substances:

Year:  2015        PMID: 25914175      PMCID: PMC4447534          DOI: 10.1002/cmdc.201500100

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  32 in total

1.  Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation.

Authors:  S H Szajnman; W Yan; B N Bailey; R Docampo; E Elhalem; J B Rodriguez
Journal:  J Med Chem       Date:  2000-05-04       Impact factor: 7.446

2.  Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.

Authors:  Julio A Urbina; Juan Luis Concepcion; Salomé Rangel; Gonzalo Visbal; Renee Lira
Journal:  Mol Biochem Parasitol       Date:  2002 Nov-Dec       Impact factor: 1.759

3.  Sterol biosynthesis inhibitors: potential chemotherapeutics against Chagas disease.

Authors:  R Docampo; G A Schmuñis
Journal:  Parasitol Today       Date:  1997-04

4.  Genetic evidence that an endosymbiont-derived endoplasmic reticulum-associated protein degradation (ERAD) system functions in import of apicoplast proteins.

Authors:  Swati Agrawal; Giel G van Dooren; Wandy L Beatty; Boris Striepen
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

Review 5.  Targeting Trypanosoma cruzi sterol 14α-demethylase (CYP51).

Authors:  Galina I Lepesheva; Fernando Villalta; Michael R Waterman
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

6.  A versatile catalyst system for Suzuki-Miyaura cross-coupling reactions of C(sp(2))-tosylates and mesylates.

Authors:  Brijesh Bhayana; Brett P Fors; Stephen L Buchwald
Journal:  Org Lett       Date:  2009-09-03       Impact factor: 6.005

7.  Design, synthesis, and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes).

Authors:  A J Schvartzapel; L Zhong; R Docampo; J B Rodriguez; E G Gros
Journal:  J Med Chem       Date:  1997-07-18       Impact factor: 7.446

8.  Head-to-head prenyl tranferases: anti-infective drug targets.

Authors:  Fu-Yang Lin; Yi-Liang Liu; Kai Li; Rong Cao; Wei Zhu; Jordan Axelson; Ran Pang; Eric Oldfield
Journal:  J Med Chem       Date:  2012-05-01       Impact factor: 7.446

9.  Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.

Authors:  Kovi Bessoff; Adam Sateriale; K Kyungae Lee; Christopher D Huston
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

10.  Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition.

Authors:  I Coppens; A P Sinai; K A Joiner
Journal:  J Cell Biol       Date:  2000-04-03       Impact factor: 10.539

View more
  4 in total

1.  In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites.

Authors:  Sergio H Szajnman; Tamila Galaka; Zhu-Hong Li; Catherine Li; Nathan M Howell; María N Chao; Boris Striepen; Vasant Muralidharan; Silvia N J Moreno; Juan B Rodriguez
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

2.  Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii.

Authors:  María N Chao; Catherine Li; Melissa Storey; Bruno N Falcone; Sergio H Szajnman; Sergio M Bonesi; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  ChemMedChem       Date:  2016-11-25       Impact factor: 3.466

Review 3.  A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).

Authors:  Mahbobeh Montazeri; Mehdi Sharif; Shahabeddin Sarvi; Saeed Mehrzadi; Ehsan Ahmadpour; Ahmad Daryani
Journal:  Front Microbiol       Date:  2017-01-20       Impact factor: 5.640

4.  A New Method for the Synthesis of 3-Thiocyanatopyrazolo[1,5-a]pyrimidines.

Authors:  Vladimir A Kokorekin; Sergey V Neverov; Vera N Kuzina; Vladimir A Petrosyan
Journal:  Molecules       Date:  2020-09-11       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.